» Authors » Charles K Moore

Charles K Moore

Explore the profile of Charles K Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofmeyer M, Haas G, Jordan E, Cao J, Kransdorf E, Ewald G, et al.
Circulation . 2023 Aug; 148(11):872-881. PMID: 37641966
Background: Dilated cardiomyopathy (DCM) can lead to advanced disease, defined herein as necessitating a durable left ventricular assist device or a heart transplant (LVAD/HT). DCM is known to have a...
2.
Jordan E, Kinnamon D, Haas G, Hofmeyer M, Kransdorf E, Ewald G, et al.
JAMA . 2023 Aug; 330(5):432-441. PMID: 37526719
Importance: Black patients with dilated cardiomyopathy (DCM) have increased familial risk and worse outcomes than White patients, but most DCM genetic data are from White patients. Objective: To compare the...
3.
Ni H, Jordan E, Kinnamon D, Cao J, Haas G, Hofmeyer M, et al.
J Am Coll Cardiol . 2023 May; 81(21):2059-2071. PMID: 37225358
Background: Cardiovascular screening is recommended for first-degree relatives (FDRs) of patients with dilated cardiomyopathy (DCM), but the yield of FDR screening is uncertain for DCM patients without known familial DCM,...
4.
Kinnamon D, Jordan E, Haas G, Hofmeyer M, Kransdorf E, Ewald G, et al.
Circulation . 2023 Mar; 147(17):1281-1290. PMID: 36938756
Background: Managing disease risk among first-degree relatives of probands diagnosed with a heritable disease is central to precision medicine. A critical component is often clinical screening, which is particularly important...
5.
Huggins G, Kinnamon D, Haas G, Jordan E, Hofmeyer M, Kransdorf E, et al.
JAMA . 2022 Feb; 327(5):454-463. PMID: 35103767
Importance: Idiopathic dilated cardiomyopathy (DCM) aggregates in families, and early detection in at-risk family members can provide opportunity to initiate treatment prior to late-phase disease. Most studies have included only...
6.
Blossom J, Lowe C, Ashley K, Kogon B, Lee S, Long R, et al.
JACC Case Rep . 2021 Jul; 3(1):69-73. PMID: 34317471
A patient with severe mitral regurgitation and chronic systolic heart failure taking inotropic support at home presents for transcatheter edge-to-edge mitral valve repair, complicated by torrential mitral regurgitation from damaged...
7.
Hall M, Vaduganathan M, Khan M, Papadimitriou L, Long R, Hernandez G, et al.
J Card Fail . 2020 May; 26(6):462-463. PMID: 32405232
No abstract available.
8.
Papadimitriou L, Moore C, Butler J, Long R
Card Fail Rev . 2019 Jun; 5(2):74-77. PMID: 31179015
Heart failure (HF) has emerged as a global epidemic and it affects about 6 million adults in the US. HF medical treatment, as recommended in guidelines, significantly improves survival and...
9.
Barker A, McDaniel D, Zhou X, He Z, Aru G, Thomas T, et al.
Am Surg . 2010 Aug; 76(8):872-8. PMID: 20726420
In cardiac transplantation settings, the initial myocardial ischemia and reperfusion may cause myocyte tissue injury and the release of allograft inflammatory factor-1 (AIF-1). This in part may trigger the innate...
10.
Zhou X, Barber W, Moore C, Tee L, Aru G, Harrison S, et al.
Res Commun Mol Pathol Pharmacol . 2007 Nov; 119(1-6):89-104. PMID: 17974099
CYP 3A4 plays a vital role in the metabolism of many drugs including immunosuppressants. An association between a transition of A --> G at position -290 of the 5'-regulatory region...